Michail S Lionakis, Nathaniel D Albert, Muthulekha Swamydas, Chyi-Chia R Lee, Pius Loetscher, Dimitrios P Kontoyiannis
Antimicrobial agents and chemotherapy 2017 MarSystemic candidiasis is a leading cause of nosocomial bloodstream infection with a high mortality rate despite treatment. Immune-based strategies are needed to improve outcomes. We previously reported that genetic deficiency in the chemokine receptor CCR1 improves survival and ameliorates tissue damage in Candida-infected mice. Here, we found that treatment of immunocompetent Candida-infected mice with the CCR1-selective antagonist BL5923 improves survival, decreases the kidney fungal burden, and protects from renal tissue injury. Copyright © 2017 American Society for Microbiology.
Michail S Lionakis, Nathaniel D Albert, Muthulekha Swamydas, Chyi-Chia R Lee, Pius Loetscher, Dimitrios P Kontoyiannis. Pharmacological Blockade of the Chemokine Receptor CCR1 Protects Mice from Systemic Candidiasis of Hematogenous Origin. Antimicrobial agents and chemotherapy. 2017 Mar;61(3)
PMID: 27993850
View Full Text